RCEL AVITA Medical, Inc.
13.05USD+0.46%Mkt Cap: 403.60M $P/E: —1d ago
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is th…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap403.60M USD
Enterprise Value439.09M USD
Revenue (TTM)75.63M USD
Gross Profit58.82M USD
Net Income (TTM)-48.59M USD
Revenue/Share2.52 USD
Last Price13.05 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees226
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-31.15
PEG—
EV/EBITDA-13.40
EV/Revenue5.81
P/S5.31
P/B-14.43
EPS (TTM)-1.41
EPS (Forward)-0.42
52W Range
3.22096% of range13.49
52W High13.49 USD
52W Low3.220 USD
Profitability
Gross Margin82.13%
Oper. Margin-31.59%
EBITDA Margin-43.32%
Profit Margin-67.85%
ROE291.81%
ROA-86.16%
Growth
Revenue Growth17.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-31.20M USD
CapEx (TTM)1.74M USD
FCF Margin-17.65%
FCF Yield-3.31%
Net Debt37.35M USD
Net Debt/EBITDA-1.14
Balance Sheet
Debt/Equity-2.77
Current Ratio0.41
Quick Ratio0.31
Book Value/Sh-0.90 USD
Cash/Share0.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJun 30, 2020
Analyst Consensus
Rating—
Target (Mean)12.06 USD
Upside (mean)-7.6%
Target Range10.81 USD – 13.69 USD
10.81-7.6% to mean13.69
# Analysts3
Ownership
Shares Out.30.93M
Float30.47M
Insiders1.52%
Institutions16.25%
Short Interest
Short Ratio8.1d
Short % Float9.42%
Short % Out.9.33%
Shares Short2.89M
Short (prev mo.)2.75M
Technical
SMA 509.303 (+40.3%)
SMA 2005.516 (+136.6%)
Beta1.99
S&P 52W Chg16.45%
Avg Vol (30d)323.28K
Avg Vol (10d)354.21K
Technical Indicators
RSI (14)72.2
MACD1.1376
MACD Signal1.1058
MACD Hist.+0.0318
BB Upper13.56 USD
BB Middle11.41 USD
BB Lower9.257 USD
BB Width37.71%
ATR (14)0.7157 USD
Vol Ratio (20d)0.81x